Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period From To Commission File Number: 001-32431 DOLBY LABORATORIES, INC. (Exact name of registrant as specified in its charter) Delaware 90-0199783 (State or othe ...

Dolby Laboratories, Inc. (NYSE:DLB) Q1 2023 Earnings Conference Call February 2, 2023 5:00 PM ET Company Participants Maggie O'Donnell - Head of Investor Relations Kevin Yeaman - Chief Executive Officer Robert Park - Chief Financial Officer Conference Call Participants Steven Frankel - Rosenblatt Paul Chung - J.P. Morgan Ralph Schackart - William Blair Jim Goss - Barrington Research Operator Ladies and gentlemen, thank you for standing by. Welcome to the Dolby Laboratories Conference Call discussing Fiscal ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended December 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period From To Commission File Number: 001-32431 DOLBY LABORATORIES, INC. (Exact name of registrant as specified in its charter) Delaware 90-0199783 (State or o ...

Dolby Laboratories, Inc. (NYSE:DLB) Q4 2022 Earnings Conference Call November 17, 2022 5:00 PM ET Company Participants Ashley Schwenoha - Senior Manager, IR Maggie O'Donnell - Head, IR Kevin Yeaman - President and CEO Robert Park - SVP and CFO Conference Call Participants Ralph Schackart - William Blair & Company L.L.C., Research Division Steven Frankel - Rosenblatt Securities Inc., Research Division Paul Chung - JPMorgan Chase & Co, Research Division Jim Goss - Barrington Research Associates, Inc., Researc ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended September 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period From To Commission File Number: 001-32431 DOLBY LABORATORIES, INC. (Exact name of registrant as specified in its charter) Delaware 90-0199783 (State or other ju ...

Dolby Laboratories, Inc. (NYSE:DLB) Q3 2022 Earnings Conference Call August 9, 2022 4:30 PM ET Company Participants Ashley Schwenoha - Senior Manager, IR Maggie O'Donnell - Head, IR Kevin Yeaman - President, CEO & Director Robert Park - SVP & CFO Conference Call Participants Steven Frankel - Rosenblatt Securities Ralph Schackart - William Blair & Company Paul Chung - JPMorgan Chase & Co. James Goss - Barrington Research Associates Operator Ladies and gentlemen, thank you for standing by. Welcome to the Dolb ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended July 1, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period From To Commission File Number: 001-32431 | --- | --- | --- | --- | --- | |---------------------------------------------------------------------------------|- ...

Dolby Laboratories, Inc. (NYSE:DLB) Q2 2022 Earnings Conference Call May 5, 2022 4:30 PM ET Company Participants Ashley Schwenoha - Senior Manager-Investor Relations Kevin Yeaman - Chief Executive Officer Robert Park - Chief Financial Officer Conference Call Participants Ralph Schackart - William Blair Paul Chung - JPMorgan Jim Goss - Barrington Research Operator Ladies and gentlemen, thank you for standing by. Welcome to the Dolby Laboratories Conference Call discussing Fiscal Second Quarter Results. Durin ...

Revenue Generation and Licensing - Dolby Laboratories generates the majority of its revenue from licensing audio technologies, with approximately 500 active licensing arrangements as of April 1, 2022[178]. - The company holds around 16,400 issued patents related to its technologies, which significantly contribute to its licensing revenue[178]. - The revenue composition for the fiscal year ending April 1, 2022, shows that 33% comes from broadcast, 21% from mobile, 17% from consumer electronics, 18% from PCs, and 11% from other sources[179]. - Dolby's key technologies include Dolby Atmos, Dolby Vision, and various audio codecs, which enhance media playback experiences across multiple platforms[179]. - The company has implemented a two-tier licensing model, where semiconductor manufacturers first license technologies before they are sold to OEMs[180]. - Dolby Cinema partnerships allow the company to earn revenue through a share of box office receipts, recognized as licensing revenue[187]. - Dolby's licensing revenue is primarily driven by the adoption of audio and imaging technologies, with foundational audio technologies expected to reflect market trends in device shipments[201]. Market Challenges and COVID-19 Impact - The COVID-19 pandemic has negatively impacted consumer purchasing activity and supply chains, affecting demand for products incorporating Dolby's technologies[195]. - The company continues to monitor the evolving situation of COVID-19 and its impact on business operations and revenue[196]. - The company faces challenges in the broadcast market due to geopolitical issues and the impact of COVID-19 on consumer demand and manufacturing capabilities[211]. - COVID-19 continues to impact the cinema market, with uncertainty regarding full capacity operations and box office receipts fluctuating[199]. - The ongoing impact of COVID-19 has negatively affected demand for cinema products and services, with supply chain constraints also posing challenges[234]. Product and Service Offerings - The company offers various services to support theatrical and television production, including equipment training and maintenance[192]. - The developer platform, Dolby.io, enables access to audio and video APIs, expanding the addressable market for the company's technologies[191]. - Dolby Cinema sites are operating at approximately 85% capacity, subject to local regulations, with over 400 theatrical titles in Dolby Vision and Dolby Atmos announced or released, up from over 375 at the end of fiscal 2021[227]. - As of the end of the second quarter of fiscal 2022, there are over 6,500 Dolby Atmos screens installed or committed, with over 2,200 Dolby Atmos theatrical titles announced or released[231]. - Major streaming partners like Netflix, Disney+, and Amazon continue to enable more content in Dolby formats, enhancing the adoption of Dolby Vision and Dolby Atmos across devices[205]. - Dolby has expanded its presence in the mobile market, with new devices from Lenovo, Xiaomi, and OPPO supporting Dolby Atmos and Dolby Vision[214]. - The company continues to focus on expanding its leadership in audio and imaging solutions for premium entertainment content, including music and gaming[200]. Financial Performance - Licensing revenue for the fiscal quarter ended April 1, 2022, was $313,833, a 3% increase from $303,585 for the same quarter in 2021[242]. - Total revenue for the fiscal year-to-date ended April 1, 2022, was $646,117, down 5% from $676,590 for the same period in 2021[242]. - Products revenue increased by 29% to $20,538 for the fiscal quarter ended April 1, 2022, compared to $15,973 for the same quarter in 2021[246]. - Gross margin for licensing was 95% for both the fiscal quarter ended April 1, 2022, and the same quarter in 2021[242]. - The company reported a gross margin percentage of 8% for products and services revenue for the fiscal quarter ended April 1, 2022, compared to a negative 2% for the same quarter in 2021[246]. - Net income attributable to controlling interest for the quarter ended April 1, 2022, was $201 million, compared to a loss of $128 million in the same quarter of the previous year, representing a 257% change[268]. Expenses and Investments - Research and Development expenses primarily consist of employee compensation, stock-based compensation, and consulting costs[249]. - Sales and marketing expenses for Q1 2022 were $84,230, an increase of $6,184 or 8% compared to $78,046 in Q1 2021, representing 25% of total revenue[251]. - General and administrative expenses for Q1 2022 were $98,693, an increase of $39,295 or 66% compared to $59,398 in Q1 2021, representing 30% of total revenue[255]. - Restructuring charges for Q1 2022 were $5,162, an increase of $4,421 or 597% compared to $741 in Q1 2021, representing 2% of total revenue[260]. - Year-to-date research and development expenses increased to $136,245, up $6,665 or 5% from $129,580 in the previous year[250]. - Year-to-date sales and marketing expenses increased to $181,400, up $27,909 or 18% from $153,491 in the previous year[251]. - Year-to-date general and administrative expenses increased to $161,137, up $47,285 or 42% from $113,852 in the previous year[255]. - Year-to-date restructuring charges decreased to $5,067, down $5,697 or 53% from $10,764 in the previous year[260]. Cash Flow and Investments - Cash and cash equivalents as of April 1, 2022, totaled $900.4 million, down from $1.2 billion as of September 24, 2021[273]. - Net cash provided by operating activities decreased by $71 million to $94.7 million for the year-to-date period ended April 1, 2022, compared to $165.6 million for the same period last year[280]. - Net cash used in investing activities increased significantly to $(247.1) million for the year-to-date period ended April 1, 2022, compared to $(15.8) million for the same period last year[281]. - The company had short and long-term investments totaling $265.8 million as of April 1, 2022, primarily in corporate bonds and government securities[272]. - The weighted-average credit quality of the investment portfolio was AA+ with a weighted-average maturity of approximately ten months as of April 1, 2022[290]. - A 10% increase in the value of the U.S. dollar would decrease the fair value of financial instruments by $2.9 million, while a 10% decrease would increase the fair value by the same amount[299]. - The total notional amounts of outstanding foreign currency contracts were $87.8 million as of April 1, 2022, compared to $51.0 million as of September 24, 2021[298]. Internal Controls and Legal Matters - The company maintains disclosure controls and procedures to ensure timely and accurate reporting of required information[302]. - There were no changes in internal control over financial reporting during the fiscal quarter ending April 1, 2022, that materially affected the internal control[304]. - The company is involved in various legal proceedings, but resolution of these matters is not expected to materially impact operating results or financial condition[307].

Dolby Laboratories, Inc. (NYSE:DLB) Q1 2022 Earnings Conference Call February 3, 2022 4:30 PM ET Company Participants Ashley Schwenoha - Senior Manager of Investor Relations Kevin Yeaman - President and Chief Executive Officer Robert Park - Senior Vice President and Chief Financial Officer Conference Call Participants Steven Frankel - Colliers Securities LLC Paul Chung - JP Morgan Operator Ladies and gentlemen, thank you for standing by. Welcome to the Dolby Laboratories Conference Call discussing Fiscal Fi ...